Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

US-based pharmaceutical company VYNE Therapeutics has completed enrolment in the randomised Phase IIb clinical trial of ...

The Delhi High Court in a landmark decision held that a candidate suffering from vitiligo is not entitled to be recruited ...

While beauty standards have begun to shift towards inclusivity and self-acceptance, living with a visible skin condition like vitiligo can still pose immense emotional and psychological challenges.

VYN201 gel being evaluated in subjects with nonsegmental vitiligoTop-line data from the 24-week double-blind portion of the trial ...

A recent population-based study from South Korea highlights the long-term dermatological complications linked to COVID-19 ...

The regenerative medicine company disappointed its shareholders with a revenue miss that has dragged down full-year results ...